Aperio Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $4.62M | Buy |
53,352
+1,452
| +3% | +$126K | 0.01% | 860 |
|
|
2020
Q3 | $3.17M | Buy |
51,900
+14,550
| +39% | +$889K | 0.01% | 907 |
|
|
2020
Q2 | $1.55M | Buy |
37,350
+14,381
| +63% | +$598K | 0.01% | 1221 |
|
|
2020
Q1 | $659K | Buy |
22,969
+13,640
| +146% | +$391K | ﹤0.01% | 1502 |
|
|
2019
Q4 | $674K | Buy |
9,329
+1,793
| +24% | +$130K | ﹤0.01% | 1650 |
|
|
2019
Q3 | $1.06M | Buy |
7,536
+21
| +0.3% | +$2.95K | ﹤0.01% | 1363 |
|
|
2019
Q2 | $1.38M | Buy |
7,515
+2,030
| +37% | +$372K | 0.01% | 1232 |
|
|
2019
Q1 | $873K | Buy |
5,485
+3,116
| +132% | +$496K | ﹤0.01% | 1431 |
|
|
2018
Q4 | $227K | Buy |
2,369
+87
| +4% | +$8.34K | ﹤0.01% | 2082 |
|
|
2018
Q3 | $322K | Buy |
2,282
+215
| +10% | +$30.3K | ﹤0.01% | 1978 |
|
|
2018
Q2 | $324K | Buy |
+2,067
| New | +$324K | ﹤0.01% | 1963 |
|